Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine

Chemico-Biological Interactions

Volumn 161, Issue 2, 2006, Pages 125-138

  Kim, Young Woo ^a,b   Ki, Sung Hwan ^a   Lee, Jong Rok ^b   Lee, Song Jin ^a   Kim, Choon Won ^c   Kim, Sang Chan ^b   Kim, Sang Geon ^a  

^a Seoul National University   (South Korea)

^b Daegu Haany University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Acetaminophen; BSO; DDB; Hepatoprotective effect; Liquiritigenin; Liver injury

Indexed keywords

AGLYCONE; ALANINE AMINOTRANSFERASE; BUTHIONINE SULFOXIMINE; CARBOXYLIC ACID DERIVATIVE; DIMETHYL 4,4' DIMEHOXY 4,6,5',6' DIMETHYLENEDIOXYBIPHENYL 2,2' DICARBOXYLIC ACID; LACTATE DEHYDROGENASE; LIQUIRITIGENIN; PARACETAMOL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VIVO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; NONHUMAN; RAT;

ACETAMINOPHEN; ACUTE DISEASE; ALANINE TRANSAMINASE; ANIMALS; BUTHIONINE SULFOXIMINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FABACEAE; FLAVANONES; GLUCOSIDES; L-LACTATE DEHYDROGENASE; LIVER; MOLECULAR STRUCTURE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33646850088     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.03.008     Document Type: Article

References (32)

1. Wang Z.Y., and Nixon D.W. Licorice and cancer. Nutr. Cancer 39 (2001) 1-11
2. Yokozawa T., Cho E.J., Rhyu D.Y., Shibahara N., and Aoyagi K. Glycyrrhizae radix attenuates peroxynitrite-induced renal oxidative damage through inhibition of protein nitration. Free Radic. Res. 39 (2005) 203-211
3. Mori H., Niwa K., Zheng Q., Yamada Y., Sakata K., and Yoshimi N. Cell proliferation in cancer prevention: effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells. Mutat. Res. Fundam. Mol. Mech. Mutagen. 480/481 (2001) 201-207
4. Kamei J., Nakamura R., Ichiki H., and Kubo M. Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to (Mai-men-dong-tang). Eur. J. Pharmacol. 469 (2003) 159-163
5. Hibasami H., Iwase H., Yoshioka K., and Takahashi H. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells. Int. J. Mol. Med. 16 (2005) 233-236
6. Takei M., Kobayashi M., Li X.D., Pollard R.B., and Suzuki F. Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine. Pathobiology 72 (2005) 117-123
7. Kim S.C., Byun S.H., Yang C.H., Kim C.Y., Kim J.W., and Kim S.G. Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity: effects on bad translocation and cytochrome c-mediated PARP cleavage. Toxicology 197 (2004) 239-251
8. Zakin D., and Boyer T.D. Drug-induced liver disease. In: Lamsback W. (Ed). Hepatology (1990), W.B. Saunders Company, Philadelphia, PA 759-762
9. Burcham P.C., and Harman A.W. Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. J. Biol. Chem. 266 (1991) 5049-5054
10. Park E.Y., Ki S.H., Ko M.S., Kim C.W., Lee M.H., Lee Y.S., and Kim S.G. Garlic oil and DDB, comprised in a pharmaceutical composition for the treatment of patients with viral hepatitis, prevents acute liver injuries potentiated by glutathione deficiency in rats. Chem. Biol. Interact. 155 (2005) 82-96
11. Masubuchi Y., Suda C., and Horie T. Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J. Hepatol. 42 (2005) 110-116
12. Gibson J.D., Pumford N.R., Samokyszyn V.M., and Hinson J.A. Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress. Chem. Res. Toxicol. 9 (1996) 580-585
13. Potter W.Z., Davis D.C., Mitchell J.R., Jollow D.J., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic necrosis. III. Cytochrome-P450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 187 (1973) 203-210
14. Son M.H., Kang K.W., Lee C.H., and Kim S.G. Potentiation of cadmium-induced cytotoxicity by sulfur amino acid deprivation through activation of extracellular signal-regulated kinase1/2 (ERK1/2) in conjunction with p38 kinase or c-jun N-terminal kinase (JNK). Complete inhibition of the potentiated toxicity by U0126 an ERK1/2 and p38 kinase inhibitor. Biochem. Pharmacol. 62 (2001) 1379-1390
15. Kim S.C., Cho M.K., and Kim S.G. Cadmium-induced non-apoptotic cell death mediated by oxidative stress under the condition of sulfhydryl deficiency. Toxicol. Lett. 144 (2003) 325-336
16. Kang K.W., Choi S.H., Ha J.R., Kim C.W., and Kim S.G. Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression. Chem. Biol. Interact. 139 (2002) 61-77
17. Rej R. Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin. Chem. 24 (1978) 1971-1979
18. Sherlock S., and Dooley J. Diseases of the Liver and Biliary System. 11th ed. (2002), Blackwell Science, London p. 23
19. Liu J., Liu Y., and Klaassen C.D. The effect of Chinese hepatoprotective medicines on experimental liver injury in mice. J. Ethnopharmacol. 42 (1994) 183-191
20. Ferguson D.R., Snyder S.K., and Cameron A.J. Hepatotoxicity in acetaminophen poisoning. Mayo Clin. Proc. 52 (1977) 246-248
21. Meeks R.G., Harrison S.D., and Bull R.J. A Histopathologic Classification of chemical-induced Injury of the Liver, Hepatotoxicology (1991), CRC Press Inc., Boca Raton, FL pp. 73-77
22. Oh S.J., Kim S.K., and Kim Y.C. Role of glutathione in metabolic degradation of dichloromethane in rats. Toxicol. Lett. 129 (2002) 107-114
23. Rumack B.H. Acetaminophen misconceptions. Hepatology 40 (2004) 10-15
24. Lee W.M. Acetaminophen and the U.S. acute liver failure study group: lowering the risks of hepatic failure. Hepatology 40 (2004) 6-9
25. Mitchell J.R., Jollow D.J., Potter W.Z., Davis D.C., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187 (1973) 185-194
26. Jollow D.J., Mitchell J.R., Potter W.Z., Davis D.C., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187 (1973) 195-202
27. Polson J., and Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 41 (2005) 1179-1197
28. Kim S.N., Kim S.Y., Yim H.K., Lee W.Y., Ham K.S., Kim S.K., Yoon M.Y., and Kim Y.C. Effect of dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylenedioxybiphenyl-2,2′-dicarboxylate (DDB) on chemical-induced liver injury. Biol. Pharm. Bull. 22 (1999) 93-95
29. El-Beshbishy H.A. The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective. J. Biochem. Mol. Biol. 38 (2005) 300-306
30. Bonis P.A., Ioannidis J.P., Cappelleri J.C., Kaplan M.M., and Lau J. Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: a meta-analysis of diagnostic test characteristics. Hepatology 26 (1997) 1035-1044
31. Kim S.G., Kim H.J., Choi S.H., and Ryu J.Y. Inhibition of lipopolysaccharide-induced I-kappaB degradation and tumor necrosis factor-alpha expression by dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB): minor role in hepatic detoxifying enzyme expression. Liver 20 (2000) 319-329
32. Kamei J., Saitoh A., Asano T., Nakamura R., Ichiki H., Iiduka A., and Kubo M. Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of Glycyrrhizae radix (licorice), a main component of the Kampo preparation Bakumondo-to (Mai-men-dong-tang). Eur. J. Pharmacol. 507 (2005) 163-168